
Gabriela Moore Wins Academic Poster Competition for Alzheimer's Research
ATRI's Gabriela R. Moore recently won the academic poster competition at the USC Center for Personalized Brain Health Annual Research Symposium.
Go Gaby!
Gabriela is a second-year Ph.D. student and a member of Dr. Oliver Bracko's Blood Flow Lab at ATRI. Her research focuses on platelet dysregulation and its role in the onset and progression of Alzheimer's disease. Gabriela aims to identify novel biomarkers for Alzheimer's disease that could support the development of early, non-invasive detection methods.
Why she's passionate about her research: Platelets sit at the intersection of several key mechanisms implicated in Alzheimer's disease, including vascular dysfunction and inflammation. They also serve as accessible indicators of cerebral health. By better understanding platelet reactivity and interactions in Alzheimer's disease, we can gain deeper insight into disease onset and progression.
Diabetes is a major risk factor for Alzheimer's disease, and platelet function is significantly altered in diabetes. Understanding how these changes contribute to vascular dysfunction in diabetes can help shed light on disease mechanisms and inform the development of more effective therapies and treatment.
#AlzheimersResearch #BiomarkerDiscovery #Neuroscience #DiabetesHealth #BrainHealth
Go Gaby!
Gabriela is a second-year Ph.D. student and a member of Dr. Oliver Bracko's Blood Flow Lab at ATRI. Her research focuses on platelet dysregulation and its role in the onset and progression of Alzheimer's disease. Gabriela aims to identify novel biomarkers for Alzheimer's disease that could support the development of early, non-invasive detection methods.
Why she's passionate about her research: Platelets sit at the intersection of several key mechanisms implicated in Alzheimer's disease, including vascular dysfunction and inflammation. They also serve as accessible indicators of cerebral health. By better understanding platelet reactivity and interactions in Alzheimer's disease, we can gain deeper insight into disease onset and progression.
Diabetes is a major risk factor for Alzheimer's disease, and platelet function is significantly altered in diabetes. Understanding how these changes contribute to vascular dysfunction in diabetes can help shed light on disease mechanisms and inform the development of more effective therapies and treatment.
#AlzheimersResearch #BiomarkerDiscovery #Neuroscience #DiabetesHealth #BrainHealth
Shared byRowan Morgan - A month ago
Log in to comment
Loading ..
Related Articles
Historic Breakthrough on the Horizon in Alzheimer’s Research
New Street Medicine Resource Center Launched to Support Healthcare for Unsheltered Communities
Alzheimer's Disease: 1984 Discovery of Amyloid & Modern Research Advances
Submit Your Abstract for the 2nd Annual Alzheimer's Research Day at USC ATRI
Debating Alzheimer's Drug Efficacy: Separating Effective Treatments from Ineffective Trials
Alzheimer's Research Evolution: From First Diagnosis to Modern Treatments
18
0/100